Genicular Nerve Block in Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis, Persistent Knee Arthritis, no Intra-articular Injection in the Last 3 Months
About this trial
This is an interventional treatment trial for Juvenile Idiopathic Arthritis focused on measuring Juvenile rheumatoid arthritis, knee joint, Nerve block
Eligibility Criteria
Inclusion Criteria:
- juvenile idiopathic arthritis with persistent knee arthritis
- age below 16
Exclusion Criteria:
- severe knee osteoarthritis
- peripheral neuropathy,
- psoriatic arthritis,
- those under anticoagulant therapy, skin infection,
- prior knee injection in the last 3 months3
- those who have an allergy to Bupivacaine
Sites / Locations
- Sohag university
Arms of the Study
Arm 1
Arm 2
Active Comparator
Other
Active genicular nerve block group
intra-articular steroid injection group
group 1 will receive genicular nerve block. The injection and US examination will be done by two experienced sonographers. They were blinded to clinical data. Patients will also be blinded for the injected substance. Each point will be injected with 2 ml of Lidocaine hydrochloride 2 % (Xylocaine, Astrazeneca). The injection will be done using the 3 point technique (superior medial, superior lateral, and inferior medial genicular nerves).
while group 2 received intra-articular triamcinolone under ultrasound guidance and through injecting the supra-patellar bursa.